Related Experiment Video
Updated: Sep 3, 2025
17:16
Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
10.4K
Glucuronides: From biological waste to bio-nanomedical applications
Pierre-Alain Burnouf1, Steve R Roffler2, Chia-Ching Wu3
1International Center for Wound Repair and Regeneration, National Cheng-Kung University, Tainan, Taiwan.
Summary
Glucuronides, once dismissed as waste, are now revolutionizing cancer therapy. These compounds enhance drug delivery and targeted activation in antibody-drug conjugates and nanomedicine, improving treatment efficacy and reducing side effects.
Area of Science:
- Biomedical Science
- Oncology
- Drug Development
Background:
- Glucuronides were historically considered biological waste products.
- Recent advancements highlight their therapeutic potential, especially in cancer treatment.
- Established therapies include glucuronide prodrugs and antibody-directed enzyme prodrug therapy.
Purpose of the Study:
- To explore novel applications of glucuronides in anti-cancer therapeutics.
- To discuss the integration of glucuronides in antibody-drug conjugates and nanomedicine.
- To highlight strategies for localized drug activation and reduced systemic toxicity.
Main Methods:
- Review of emerging therapeutic strategies utilizing glucuronides.
- Analysis of glucuronide application in antibody-drug conjugates.
- Examination of glucuronide use in nanomedicine for targeted drug delivery.
Main Results:
- Glucuronides serve as effective vectors to enhance drug pharmacokinetics.
- Localized drug activation at tumor sites is achieved through glucuronide conjugation.
- Systemic toxicity is significantly decreased by targeted delivery mechanisms.
Conclusions:
- Glucuronides offer promising avenues for advanced anti-cancer therapies.
- Their unique properties are being leveraged in innovative drug delivery systems.
- Future strategies focus on optimizing glucuronide-based treatments for improved patient outcomes.
Related Concept Videos
01:24Phase II Reactions: Glucuronidation
722
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
722
01:16Drug Biotransformation: Overview
2.6K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.6K
01:14Drug Metabolism: Phase II Reactions
4.0K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.0K
01:19Phase II Reactions: Miscellaneous Conjugation Reactions
106
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
106
01:14Phase II Conjugation Reactions: Overview
298
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
298
01:22Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
341
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
341